Xeris Pharmaceuticals (Series A)
Funding Details
- Awarder
- Inbox
- Date Award
- May 19, 2017
- Vertical
- Biopharmaceuticals
- Funding URL
- View Funding Page
- Funding Amount:
- $30,000,000
Company Info
- Company Description
- Xeris is an Austin, Texas-based, specialty biopharmaceutical company developing improved and differentiated injectable therapeutics for multiple indications including diabetes. The company's proprietary XeriSol(TM) and XeriJect(TM) formulation technologies allow for the subcutaneous and intradermal delivery of highly concentrated, non-aqueous, ready-to-inject formulations of peptides, proteins, antibodies and small molecules using auto-injectors, multi-dose pens and pumps.
- Market
- Healthcare
- Location
- Austin, Texas, USA
- Coinvestors
- Merieux Developpement